Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Acker

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The Israel Medical Association Journal : IMAJ|January 19, 2010
Tefillin and acupunctureFabian Acker
Translational Lung Cancer Research|January 20, 2025
Can circulating tumor DNA guide treatment de-escalation in metastatic lung adenocarcinoma harboring actionable genomic alterations?Fabian Acker, Martin Sebastian
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Systemic Treatment for Brain Metastases in NSCLC: A New ChapterFabian Acker, Friederike C Althoff, Martin Sebastian
Cancer Immunology, Immunotherapy : CII|August 23, 2018
Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicityFrank Neumann, Fabian Acker, Claudia Schormann, et al.
Frontiers in Oncology|January 3, 2022
<i>KRAS</i> Mutations in Squamous Cell Carcinomas of the LungFabian Acker, Jan Stratmann, Lukas Aspacher, et al.
Clinical Lung Cancer|September 11, 2022
Study Design and Rationale for the PACE-LUNG Trial: A Multicenter, Single-Arm, Phase II Clinical Trial Evaluating the Efficacy of Additional Chemotherapy for Patients with EGFRm NSCLC with the Continued Presence of Plasma ctDNA EGFRm at Week 3 After Start of Osimertinib First-Line TreatmentFabian Acker, Lukas Aguinarte, Friederike Althoff, et al.
Oncology Research and Treatment|March 25, 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted TherapiesFabian Acker, Jingting Luan, Puyan Soltani Germy, et al.
Oncology Research and Treatment|April 4, 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell EngagersMarcel Kemper, Puyan Soltani Germy, Fabian Acker, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2025
Efficacy and safety of immune checkpoint inhibition combined with concurrent chemoradiotherapy in patients with stage III unresectable non-small cell lung cancer: A systematic review and meta-analysisFabian Acker, Martin Reck, Daniel Martin, et al.
Plos One|November 9, 2019
Obesity is associated with an impaired survival in lymphoma patients undergoing autologous stem cell transplantationSebastian Scheich, Julius C Enßle, Victoria T Mücke, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Israel Medical Association Journal : IMAJ|January 19, 2010
Tefillin and acupunctureFabian Acker
Translational Lung Cancer Research|January 20, 2025
Can circulating tumor DNA guide treatment de-escalation in metastatic lung adenocarcinoma harboring actionable genomic alterations?Fabian Acker, Martin Sebastian
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Systemic Treatment for Brain Metastases in NSCLC: A New ChapterFabian Acker, Friederike C Althoff, Martin Sebastian
Cancer Immunology, Immunotherapy : CII|August 23, 2018
Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicityFrank Neumann, Fabian Acker, Claudia Schormann, et al.
Frontiers in Oncology|January 3, 2022
<i>KRAS</i> Mutations in Squamous Cell Carcinomas of the LungFabian Acker, Jan Stratmann, Lukas Aspacher, et al.
Clinical Lung Cancer|September 11, 2022
Study Design and Rationale for the PACE-LUNG Trial: A Multicenter, Single-Arm, Phase II Clinical Trial Evaluating the Efficacy of Additional Chemotherapy for Patients with EGFRm NSCLC with the Continued Presence of Plasma ctDNA EGFRm at Week 3 After Start of Osimertinib First-Line TreatmentFabian Acker, Lukas Aguinarte, Friederike Althoff, et al.
Oncology Research and Treatment|March 25, 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted TherapiesFabian Acker, Jingting Luan, Puyan Soltani Germy, et al.
Oncology Research and Treatment|April 4, 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell EngagersMarcel Kemper, Puyan Soltani Germy, Fabian Acker, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2025
Efficacy and safety of immune checkpoint inhibition combined with concurrent chemoradiotherapy in patients with stage III unresectable non-small cell lung cancer: A systematic review and meta-analysisFabian Acker, Martin Reck, Daniel Martin, et al.
Plos One|November 9, 2019
Obesity is associated with an impaired survival in lymphoma patients undergoing autologous stem cell transplantationSebastian Scheich, Julius C Enßle, Victoria T Mücke, et al.
Pageof 3